We participated in the meeting of distributors of Mgi in Mexico and we learned more about the possibilities of applying NGS in clinical areas such as oncology and virology, as well as in research or agriculture.
We visited the MGI laboratory and carried out tests to test first-hand the different clonal technology sequencing platforms, which allow access to the highest quality and accuracy values on the market since they replicate the original material instead of being a copy of the copy.
It has been a more than inspiring visit and we return excited by the opportunities presented by this effervescent area of molecular biology for the future of diagnosis and research.
Contact us for more information about MGI, its products and applications.
